Fibrosing alveolitis associated with amiodarone.
We report a patient with fibrosing alveolitis associated with amiodarone therapy. Review of the literature suggests that amiodarone induced pulmonary disease generally occurs on a maintenance dose of at least 400 mg of amiodarone daily; there is however a wide range in the duration of therapy or total dose administered prior to presentation.
D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001572:Benzofurans / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D013610:Tachycardia / Q000188:drug therapy; D013997:Time Factors
D001572:Benzofurans; D000638:Amiodarone